Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
137 participants
OBSERVATIONAL
2018-02-28
2021-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives
1. Establish the prevalence of hydrosalpinx in the recurrent miscarriage population.
2. Establish the prognosis of women diagnosed with recurrent miscarriage with concurrent hydrosalpinx.
3. Explore the role of tubal surgery for improving reproductive outcomes in women with recurrent miscarriage population and hydrosalpinx.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Value of Prenatal Ultrasound in Complicated Twin Pregnancy and Its Correlation With Chromosomal Anomalies
NCT02732717
3D Ultrasound to Assess in Recurrent Miscarriage
NCT06164015
Prevalence of Congenital Uterine Malformations
NCT01487616
Angular Pregnancy - Ultrasound Definition and Correlation With Clinical Outcomes
NCT06262373
Machine Learning Miscarriage Management Clinical Decision Support Tool Study
NCT06384144
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Women with recurrent miscarriage and no hydrosalpinx
Hysterosalpingo-contrast-sonogram
A contrast ultrasound scan to examine fallopian tube pathology and blockage
Women with recurrent miscarriage and concurrent hydrosalpinx
Hysterosalpingo-contrast-sonogram
A contrast ultrasound scan to examine fallopian tube pathology and blockage
Women with recurrent miscarriage and treated hydrosalpinx
Hysterosalpingo-contrast-sonogram
A contrast ultrasound scan to examine fallopian tube pathology and blockage
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hysterosalpingo-contrast-sonogram
A contrast ultrasound scan to examine fallopian tube pathology and blockage
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women diagnosed with recurrent miscarriage i.e. 2 or more miscarriages
* Ability to give informed consent
Exclusion Criteria
* Allergy to sonographic gel used for ultrasound scanning
* Anatomical anomaly meaning transvaginal ultrasound scan not possible
* Stenosed/occluded cervix meaning contrast media unable to be introduced via cervix
* Inability to give informed consent
* Pregnant at the time of recruitment
* Declined recruitment
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tommy's
OTHER
University of Birmingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Jayasish Ghosh
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Birmingham Womens Hospital
Birmingham, West Midands, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS ID 232650
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.